Clinical Presentation and Clinical Outcomes in Chernobyl-related Paediatric Thyroid Cancers: What Do We Know Now? What Can We Expect in the Future?

Clinical Oncology

Volumn 23, Issue 4, 2011, Pages 268-275

  Tuttle, R M ^a   Vaisman, F ^a   Tronko, M D ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

Author keywords

Chernobyl; Outcomes; Radiation; Thyroid cancer

Indexed keywords

RADIOACTIVE IODINE; THYROGLOBULIN;

ARTICLE; BELARUS; CANCER RECURRENCE; CANCER SURVIVAL; CHERNOBYL ACCIDENT; CHILD; CLINICAL FEATURE; CYTOLOGY; ECHOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MORTALITY; PEDIATRICS; PRIORITY JOURNAL; RADIOACTIVE WASTE; RUSSIAN FEDERATION; THYROGLOBULIN BLOOD LEVEL; THYROID CANCER; UKRAINE;

ADOLESCENT; CARCINOMA, PAPILLARY; CHERNOBYL NUCLEAR ACCIDENT; CHILD; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASMS, RADIATION-INDUCED; PROGNOSIS; RADIOACTIVE HAZARD RELEASE; REPUBLIC OF BELARUS; RUSSIA; THYROID NEOPLASMS; TREATMENT OUTCOME; UKRAINE;

EID: 79955024097     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2011.01.178     Document Type: Article

References (49)

1. Kazakov V.S., Demidchik E.P., Astakhova L.N. Thyroid cancer after Chernobyl. Nature 1992, 359(6390):21.
2. Prisyazhiuk A., Pjatak O.A., Buzanov V.A., et al. Cancer in the Ukraine, post-Chernobyl. Lancet 1991, 338(8778):1334-1335.
3. Baverstock K., Egloff B., Pinchera A., et al. Thyroid cancer after Chernobyl. Nature 1992, 359(6390):21-22.
4. Bennett B., Repacholi M., Carr Z. Health effects of the Chernobyl accident and special care programmes 2006, World Health Organization, Geneva.
5. Pacini F., Vorontsova T., Demidchik E.P., et al. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J Clin Endocrinol Metab 1997, 82(11):3563-3569.
6. Tronko M.D., Bogdanova T.I., Komissarenko I.V., et al. Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: statistical data and clinicomorphologic characteristics. Cancer 1999, 86(1):149-156.
7. Rybakov S.J., Komissarenko I.V., Tronko N.D., et al. Thyroid cancer in children of Ukraine after the Chernobyl accident. World J Surg 2000, 24(11):1446-1449.
8. Spinelli C., Bertocchini A., Antonelli A., et al. Surgical therapy of the thyroid papillary carcinoma in children: experience with 56 patients < or =16 years old. J Pediatr Surg 2004, 39(10):1500-1505.
9. Rogounovitch T.I., Saenko V.A., Ashizawa K., et al. TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer. Oncol Rep 2006, 15(4):949-956.
10. Demidchik Y.E., Demidchik E.P., Reiners C., et al. Comprehensive clinical assessment of 740 cases of surgically treated thyroid cancer in children of Belarus. Ann Surg 2006, 243(4):525-532.
11. Rumyantsev P.O., Saenko V.A., Ilyin A.A., et al. Radiation exposure does not significantly contribute to the risk of recurrence of Chernobyl thyroid cancer. J Clin Endocrinol Metab 2010, 17.
12. Oliynyk V., Epshtein O., Sovenko T., et al. Post-surgical ablation of thyroid residues with radioiodine in Ukrainian children and adolescents affected by post-Chernobyl differentiated thyroid cancer. J Endocrinol Invest 2001, 24(6):445-447.
13. Tronko M., Bogdanova T., Likhtarev I., et al. Thyroid gland and radiation (fundamental and applied aspects): 20-years after the Chernobyl accident. Radiation Risk Perspectives 2006, Elsevier, Nagasaki. Y. Shibata, H. Namba, K. Suzuki, M. Tomonaga (Eds.).
14. Tuttle R.M., Tala H., Shah J., et al. Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system. Thyroid 2010, 20(12):1341-1349.
15. Hay I.D., Gonzalez-Losada T., Reinalda M.S., et al. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg 2010, 34(6):1192-1202.
16. Hundahl S.A., Fleming I.D., Fremgen A.M., et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998, 83(12):2638-2648.
17. Hay I.D., Thompson G.B., Grant C.S., et al. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg 2002, 26(8):879-885.
18. Altekruse S., Kosary C., Krapcho M., et al. SEER Cancer Statistics Review, 1975-2007 2010, National Cancer Institute, Bethesda, MD, Available at:http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
19. Elisei R., Molinaro E., Agate L., et al. Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. J Clin Endocrinol Metab 2010, 95(4):1516-1527.
20. Elisei R., Schlumberger M., Driedger A., et al. Follow-up of low-risk differentiated thyroid cancer patients who underwent radioiodine ablation of postsurgical thyroid remnants after either recombinant human thyrotropin or thyroid hormone withdrawal. J Clin Endocrinol Metab 2009, 22:22.
21. Mazzaferri E.L., Kloos R.T. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001, 86(4):1447-1463.
22. Schlumberger M., De Vathaire F., Travagli J.P., et al. Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab 1987, 65(6):1088-1094.
23. Zimmerman D., Hay I.D., Gough I.R., et al. Papillary thyroid carcinoma in children and adults: long-term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery 1988, 104(6):1157-1166.
24. La Quaglia M.P., Black T., Holcomb G.W., et al. Recurrence and morbidity in differentiated thyroid carcinoma in children. Surgery 1988, 104(6):1149-1156.
25. Dottorini M.E., Vignati A., Mazzucchelli L., et al. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. J Nucl Med 1997, 38(5):669-675.
26. Newman K.D., Black T., Heller G., et al. Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group. Ann Surg 1998, 227(4):533-541.
27. Welch Dinauer C.A., Tuttle R.M., Robie D.K., et al. Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults. Clin Endocrinol (Oxf) 1998, 49(5):619-628.
28. Vassilopoulou-Sellin R., Goepfert H., Raney B., et al. Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term follow-up. Head Neck 1998, 20(6):549-555.
29. Segal K., Shvero J., Stern Y., et al. Surgery of thyroid cancer in children and adolescents. Head Neck 1998, 20(4):293-297.
30. Jarzab B., Handkiewicz Junak D., Wloch J., et al. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children. Eur J Nucl Med 2000, 27(7):833-841.
31. Grigsby P.W., Gal-or A., Michalski J.M., et al. Childhood and adolescent thyroid carcinoma. Cancer 2002, 95(4):724-729.
32. Demidchik Y.E., Saenko V.A., Yamashita S. Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present. Arq Bras Endocrinol Metabol 2007, 51(5):748-762.
33. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 2007, 57(1):43-66.
34. Giuffrida D., Scollo C., Pellegriti G., et al. Differentiated thyroid cancer in children and adolescents. J Endocrinol Invest 2002, 25(1):18-24.
35. Gorlin J.B., Sallan S.E. Thyroid cancer in childhood. Endocrinol Metab Clin North Am 1990, 19(3):649-662.
36. Harach H.R., Williams E.D. Childhood thyroid cancer in England and Wales. Br J Cancer 1995, 72(3):777-783.
37. Hung W., Sarlis N.J. Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review. Thyroid 2002, 12(8):683-702.
38. McGregor L.M., Rosoff P.M. Follicle-derived thyroid cancer in young people: the Duke experience. Pediatr Hematol Oncol 2001, 18(2):89-100.
39. Skinner M.A. Cancer of the thyroid gland in infants and children. Semin Pediatr Surg 2001, 10(3):119-126.
40. Machens A., Lorenz K., Nguyen Thanh P., et al. Papillary thyroid cancer in children and adolescents does not differ in growth pattern and metastatic behavior. J Pediatr 2010, 157(4):648-652.
41. Furlan J.C., Rosen I.B. Prognostic relevance of previous exposure to ionizing radiation in well-differentiated thyroid cancer. Langenbecks Arch Surg 2004, 389(3):198-203.
42. Gow K.W., Lensing S., Hill D.A., et al. Thyroid carcinoma presenting in childhood or after treatment of childhood malignancies: an institutional experience and review of the literature. J Pediatr Surg 2003, 38(11):1574-1580.
43. Kikuchi S., Perrier N.D., Cheah W.K., et al. Complication of thyroidectomy in patients with radiation-induced thyroid neoplasms. Arch Surg 2004, 139(11):1185-1188.
44. Naing S., Collins B.J., Schneider A.B. Clinical behavior of radiation-induced thyroid cancer: factors related to recurrence. Thyroid 2009, 19(5):479-485.
45. Rubino C., Cailleux A.F., De Vathaire F., et al. Thyroid cancer after radiation exposure: characteristics of follicular cell-derived thyroid carcinomas occurring after external radiation exposure: results of a case control study nested in a cohort. Eur J Cancer 2002, 38(5):645-647.
46. Samaan N.A., Schultz P.N., Ordonez N.G., et al. A comparison of thyroid carcinoma in those who have and have not had head and neck irradiation in childhood. J Clin Endocrinol Metab 1987, 64(2):219-223.
47. La Quaglia M.P., Black T., Holcomb G.W., et al. Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group. J Pediatr Surg 2000, 35(6):955-959. discussion 960.
48. Cooper D.S., Doherty G.M., Haugen B.R., et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009, 19(11):1167-1214.
49. Durante C., Haddy N., Baudin E., et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 2006, 91(8):2892-2899.